Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

Realcan Pharmaceutical to Buy Majority Stake in First-Class Medical Device Maker for 151 Million Yuan

MT NewswiresFeb 24 06:00 ET

Realcan Pharmaceutical Group (002589.SZ): First repurchase of 4.2918 million shares involving a capital of 12.7583 million yuan.

Glonghui reported on February 14 that Realcan Pharmaceutical Group (002589.SZ) announced that on February 14, 2025, the company first repurchased shares through a dedicated securities account for Share Buyback in a centralized bidding manner, with the number of repurchased shares being 4.29183 million shares, accounting for 0.29% of the company's total equity. Among these, the highest Fill Price was 2.99 yuan/share, the lowest Fill Price was 2.93 yuan/share, and the total amount of the transaction was 12.7583 million yuan (excluding trading fees).

Gelonghui FinanceFeb 14 04:08 ET

Realcan Pharmaceutical Group (002589.SZ): Share repurchase has not yet been implemented.

Gelonghui January 9丨 Realcan Pharmaceutical Group (002589.SZ) announced that as of December 31, 2024, the company has not yet implemented a share buyback.

Gelonghui FinanceJan 9 05:24 ET

Realcan Pharmaceutical Group (SZSE:002589) Stock Falls 10% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend

Simply Wall StJan 6 00:48 ET

Realcan Pharmaceutical Group (002589.SZ) will distribute 0.07 yuan for every 10 shares in the first three quarters, with the equity registration date on November 28.

realcan pharmaceutical group (002589.SZ) has announced that the company will implement equity distribution for the first three quarters of 2024, to all...

Zhitong FinanceNov 22, 2024 07:34 ET